---
$id: https://graph.org.ai/products/commodity/51271604
$type: Product
source: UNSPSC
code: "51271604"
title: "Butanilicaine"
class: "51271600"
classTitle: "Anaesthetic amides"
family: "51270000"
familyTitle: "Anaesthetic drugs and related adjuncts and analeptics"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Butanilicaine

**UNSPSC Code**: 51271604
**Class**: [Anaesthetic amides](Anaesthetic amides.mdx)
**Family**: [Anaesthetic drugs and related adjuncts and analeptics](../Anaesthetic drugs and related adjuncts and analeptics.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anesthetic agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7X3WV51F4N. European Medicines Agency schedules Butanilicaine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06003MIG. Butanilicaine generally arises in the molecular formula C13H19CLN2O. The term BUTANILICAINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 21 no. 12 1967, list 7.) BUTANILICAINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule butanilicaine under HS 29242995 and SITC 51479. As of Q4 2014, BUTANILICAINE remains the US FDA Preferred Term for this commodity. Butanilicaine bears US NLM identifiers UMLS ID C0054241 and NCI Concept Code C96327. SMILES: CLC1C(NC(=O)CNCCCC)C(CCC1)C.

